This filer is no longer a domestic reporting company, so the score does not apply to it now. Its history is below.
Hover or tap a dot to see the filings behind that score.
Theralink Technologies, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The registrant is experiencing delays in the compilation of certain financial and other information required to be included in the form. The Company does expect that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date
NT 10-Q, filed 2024-02-15 · accounts not ready
Theralink Technologies, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The registrant is experiencing delays in the compilation of certain financial and other information required to be included in the form. The Company does expect that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date
Theralink Technologies, Inc., a Nevada corporation (the “ Company ”), is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended September 30, 2023 (the “ Form 10-K ”). The Company could not complete the filing of its Annual Report on Form 10-K for the period ended September 30, 2023, due to a delay in obtaining and compiling information required to be included in the Company’s Form 10-K, which delay could not be eliminated by the Company without unreasonable effort and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company will file its Form 10-K no later than the fifteenth calendar day following the prescribed due date
Theralink Technologies, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The registrant is experiencing delays in the compilation of certain financial and other information required to be included in the form . The Company does expect that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date
Theralink Technologies, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2022 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The Company experienced staffing issues during the quarter due to turnover and an extended absence within the accounting department. The Company does expect that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date
Theralink Technologies, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The Company experienced staffing interruptions due to turnover within the accounting department which have prevented the Company’s management from completing the financial statements within the prescribed time period. The Company does expect that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date
Theralink Technologies, Inc. (the “Company”) is unable to file its Annual Report on Form 10-Q for the fiscal quarter ended December 31, 2021 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The Company has experienced staffing interruptions and multiple absences due to COVID-19, which have prevented the Company’s management from completing the financial statements within the prescribed time period. The Company does expect that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date
Theralink Technologies, Inc. (the “Company”) is unable to file its Annual Report on Form 10-K for the fiscal year ended September 30, 2021 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense. The Company has experienced staffing interruptions and multiple absences due to COVID-19, which have prevented the Company’s management from completing the financial statements within the prescribed time period. The Company does expect that the Form 10-K will be filed on or before the fifteenth calendar day following the prescribed due date
2021-06-08auditor changed or resigned SEC →
2021-04-20accounts declared unreliable SEC →
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice